PolyPeptide secures revolving credit facility
PolyPeptide Group / Key word: Financing PolyPeptide secures revolving credit facility 02.10.2023 / 07:00 CET/CEST Media Release PolyPeptide secures revolving...
Source: marketscreener.com
Draupnir Holding News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Draupnir Holding. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Draupnir Holding Today - Breaking & Trending Today
Transformational progress taking shape, profitability impacted by rapid expansion appointment of Marc Augustin as new CFO
PolyPeptide Group / Key word(s): Half Year Results Transformational progress taking shape, profitability impacted by rapid expans...
Source: businessinsider.com
Transformational progress taking shape, profitability impacted by rapid expansion – appointment of Marc Augustin as new CFO - adhoc - Börsennachrichten
PolyPeptide Group Key word Half Year Results Transformational progress taking shape profitability impacted by rapid expansion – appointment of Marc Augustin as new CFO 15Aug2023 0700 CETCEST Release
Source: stock-world.de
PolyPeptide Group prices IPO at CHF 64.00 per share and starts trading on the Swiss Stock Exchange
About PolyPeptide Group PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one-half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with more than 900 employees, its diversity brings breadth, depth o...
Source: dgap.de
EQS-News: PolyPeptide Group legt IPO-Angebotspreis bei CHF 64.00 pro Aktie fest und beginnt Handel an der Schweizer Börse
EQS-News: PolyPeptide Group legt IPO-Angebotspreis bei CHF 64.00 pro Aktie fest und beginnt Handel an der Schweizer Börse PolyPeptide Group legt IPO-Angebotspreis bei CHF 64.00 pro Aktie fest und beginnt Handel an der Schweizer Börse 29.04.2021 / 07:00 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. FOR RELEASE IN SWITZERLAND - THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT FORWARD IT OR ITS CONTENTS T...
Source: finanznachrichten.de